Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-28

Clinical Trial Update: Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients [NA]

View source ↗

Summary

A completed clinical trial sponsored by Alexandria University evaluated the effects of curcumin and pentoxifylline in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)
  • Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Alexandria University | Conditions: Chronic Kidney Disease | NA | Status: COMPLETED